Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study Article

Nezhat, F, Wadler, S, Muggia, F et al. (2004). Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study . GYNECOLOGIC ONCOLOGY, 93(1), 144-148. 10.1016/j.ygyno.2003.12.021

cited authors

  • Nezhat, F; Wadler, S; Muggia, F; Mandeli, J; Goldberg, G; Rahaman, J; Runowicz, C; Murgo, AJ; Gardner, GJ

sustainable development goals

authors

publication date

  • April 1, 2004

webpage

published in

keywords

  • CANCER
  • CHEMOTHERAPY
  • IN-VIVO
  • INHIBITOR
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • PROTEIN-KINASE-C
  • RANDOMIZED TRIAL
  • SQUAMOUS-CELL CARCINOMA
  • Science & Technology
  • UCN-01
  • bryostatin (NSC 339555)
  • cervical cancer
  • cisplatin

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 144

end page

  • 148

volume

  • 93

issue

  • 1